Melhores podcasts sobre Biopharma (2023)

P

Pathfinders in Biopharma

1
Biotech M&A Booms, But Have Buyouts Reached a Tipping Point? 17:04

4d ago17:04

17:04

In the latest episode of Pathfinders, Senior Biotechnology Analyst Gregory Renza discusses what’s driving the latest spate of biotech M&A activity — the new players and partnership dynamics that are creating what he calls “a landscape of competition” in the broader market.Por RBC Capital Markets

P

Pathfinders in Biopharma

1
Global Blood Therapeutics Commitment to Sickle-Cell Innovation 22:29

15d ago22:29

22:29

In this rebroadcast episode, we flash back to a previous interview with Dr. Ted W. Love, President and CEO of Global Blood Therapeutics (GBT). Dr. Love spoke with our biotechnology analyst Gregory Renza about GBT’s mission-driven culture which led to the development of Oxbryta, the company’s breakthrough sickle-cell treatment, as well as the specif…

D

Driving Digital in Biopharma

1
Design for the future and deliver progress over perfection 41:43

1M ago41:43

41:43

In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, talks with Michel Rider, VP Digital, Analytics and Performance at GSK. Michel reflects on their multi-year quest to modernize digital, data, and analytics capabilities across Development – sharing insights for achieving near-term wins while planning for the future. There …

P

Pathfinders in Biopharma

1
Is This the Breakthrough Moment for Genetic Medicine? 17:25

2M ago17:25

17:25

Genetic medicine is poised to unlock more value for patients and investors due to disruptive technologies like mRNA, siRNA and gene editing. With an estimated 27 genetic medicines already approved, RBC’s biotechnology analyst Luca Issi explains how these technologies could be used next, and why companies able to combine the right choice of interven…

E

Evaluating Biopharma

1
Episode: 8 - The Financial Impact of a Continuous Bioprocessing Strategy 20:08

2M ago20:08

20:08

Joseph Shultz, VP and technical head of biologics and vaccines at Resilience, and John Bonham-Carter, board member and VP of business development and product management at Erbi Biosystems, discuss the financial considerations biopharma companies face when implementing a continuous strategy. Shultz talks about the mindset of the senior leadership at…

E

Evaluating Biopharma

1
Episode: 7 - Implementing an Efficient Allogeneic Cell Therapy Manufacturing Strategy 27:22

3M ago27:22

27:22

Marty Giedlin, vice president and head of technology operations at Senti Bio, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, to share his experiences and provide advice on how allogeneic cell therapy companies can implement better manufacturing strategies. He discusses understanding and managing man…

D

Driving Digital in Biopharma

1
Rethink it: Digital is not a thing, digital is a means 47:58

3M ago47:58

47:58

In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Jason Bronfeld, Head of Product Development IT at Bristol-Myers Squibb, about the industry re-perceiving itself and capitalizing on the power of digital. When it comes to evolving ways of operating to an ever-better model for the future, a mindset shift is essential – digi…

E

Evaluating Biopharma

1
Episode: 06 - Process Intensification: PAT, AI, ML to Support Intensified Bioprocessing 19:15

4M ago19:15

19:15

Arthi Narayanan, innovation team leader of pharma technical operations at Genentech, and John Bonham-Carter, board member and VP of business development and product management at Erbi Biosystems, discuss how process analytical technology, artificial intelligence, and machine learning support intensified bioprocessing and improve inefficiencies. Nar…

P

Pathfinders in Biopharma

1
The Hidden Revolution Set to Turn US Healthcare on its Head 19:07

4M ago19:07

19:07

In the latest episode of Pathfinders, our Healthcare technology analyst Sean Dodge explores a quiet but accelerating revolution in the way US healthcare works – and the new breed of companies poised to benefit.Por RBC Capital Markets

E

Evaluating Biopharma

1
Episode: 05 - Navigating Scale-Up Challenges in Protein Production 20:45

5M ago20:45

20:45

Parrish Galliher, an independent bioprocess consultant, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, about the context-dependent issues that arise when scaling-up protein production. Gallaher uses a case study involving scaling challenges in E. coli bioprocesses that produced a product at 50% pote…

E

Evaluating Biopharma

1
Episode 4: Anticipating Disruptions: Identifying and Planning for Shortages 19:42

6M ago19:42

19:42

In the biopharma space, nearly every moving part is contingent upon a functioning supply chain. In this month’s episode, moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, speaks with Rich Musa, director and head of supply chain at Cipla Therapeutics, about anticipating supply chain disruptions and planning for sho…

P

Pathfinders in Biopharma

1
The Big Picture for Biotech 21:49

6M ago21:49

21:49

In this latest episode, our head of biotech research Brian Abrahams shares a big picture analysis of the industry, outlining the long-term disruptions and opportunities ahead for biotech.Por RBC Capital Markets

D

Driving Digital in Biopharma

1
2022 Life Sciences Tech Trends - The Metaverse Continuum for Supply Chain 23:27

6M ago23:27

23:27

In this episode, Tom Lehmann talks with Natasha Kelly, a data scientist within Accenture's Applied Intelligence Group who focuses on advanced analytic solutions in life sciences manufacturing and supply chain. Tom and Natasha discuss the 2022 Life Sciences Technology Vision through a supply chain lens, delving into how each of the report's four tre…

P

Pathfinders in Biopharma

1
Why Biopharma Investment Requires a Different Mindset 22:52

7M ago22:52

22:52

In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.Por RBC Capital Markets

D

Driving Digital in Biopharma

1
2022 Life Sciences Tech Trends - The Metaverse Continuum for Biopharma R&D 14:19

7M ago14:19

14:19

In this episode, Tom Lehmann talks with Accenture’s Ross Wooddisse, Managing Director and Life Sciences R&D Lead in Europe, about the 2022 Life Sciences Technology Vision and what the Metaverse continuum means for Biopharma R&D. They discuss how science turns into medicine, a new generation of digital trial capabilities and the fundamental opportun…

E

Evaluating Biopharma

1
Episode: 3 - Cell and Gene Therapy: Managing the ‘Build or Buy’ Decision 22:36

7M ago22:36

22:36

Dave Backer, founder of DB Biologics and former chief commercial officer at Oxford Biomedica, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, about the complex business and technological decisions companies face when navigating supply chain issues in the cell and gene therapy (CGT) market. Today’s co…

E

Evaluating Biopharma

1
Episode: 2 - Operational Efficiencies: Lower Operational Costs by Reducing Clinical GMP Sampling 25:12

8M ago25:12

25:12

In this episode, Josefine Persson, Genentech associate director, and Ben Locwin, Black Diamond Networks vice president of project solutions, discuss how the cost of oversampling from clinical GMP runs versus development sources equates to high expenses and lost opportunities in moving a new project into GMP manufacturing. Persson also talks about t…

P

Pathfinders in Biopharma

1
The Optimism Behind the Biopharma Market 25:49

8M ago25:49

25:49

In this episode, Dr. Chen Yu, Founder and Managing Partner at TCG X and Noël Brown, Head of U.S. Biotechnology Investment Banking at RBC Capital Markets, discuss why they remain optimistic about biotech and what’s happening behind the scenes in public and private markets.Por RBC Capital Markets

E

Evaluating Biopharma

1
Episode 000: Introducing the Evaluating Biopharma Podcast 2:07

9M ago2:07

2:07

Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary informati…

E

Evaluating Biopharma

1
Episode 001: The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection 21:53

9M ago21:53

21:53

In the inaugural episode of Evaluating Biopharma podcast, CPI’s Simon Hawdon speaks with Moderator John Bonham-Carter about the benefits of converting from batch to continuous processing and the critical decisions involved in making a high-quality product. Hawdon talks about whether there is an optimal time for process conversion, key equipment fea…

D

Driving Digital in Biopharma

1
2022 Life Sciences Tech Trends Overview 31:20

9M ago31:20

31:20

In this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture’s Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future.Por Accenture

D

Driving Digital in Biopharma

1
Enabling tomorrow's science through digital 40:31

10M ago40:31

40:31

In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Anders Persson – Executive Director, Ecosystem Strategy & Innovation, AstraZeneca, about the role of digital and data in the transformation of global drug development and the value of an ecosystem and partnership strategy in R&D.…

D

Driving Digital in Biopharma

1
From documents to data - Regulatory's future? 40:43

11M ago40:43

40:43

Tom Lehmann and Eddie Reilly, Chief regulatory officer and head of global regulatory affairs, Sanofi discuss delivering new therapies to patients more efficiently and how that’s enabled by regulatory affairs - from standardizing data and harnessing AI to the more proficiently exchanging data with health authorities.…

D

Driving Digital in Biopharma

1
Raising the innovation bar in early research and development 38:31

1y ago38:31

38:31

Host Tom Lehmann talks with Lars Fogh Iversen, Senior Vice Present for Digital Science & Innovation at Novo Nordisk. They discuss the journey to accelerate research and early development through laboratory automation, data management, AI and digital research.Por Accenture

D

Driving Digital in Biopharma

1
Enabling scientific curiosity through digital in drug discovery 33:51

1y ago33:51

33:51

In Episode 11, host Tom Lehmann and guest Julie Huxley-Jones, GSK, discuss the mindset of scientific curiosity, innovation and collaboration and its role on the impact of digital in scientific discovery. They talk about the unique journey of digital in discovery research and how it’s increasing productivity and innovation.…

P

Pathfinders in Biopharma

1
Biotech Investors: How to Find Value in a Bear Market 28:55

1y ago28:55

28:55

How are top investors navigating the longest biotech bear market in almost 20 years? RBC Capital Markets Healthcare Desk Sector Strategist Chris McCarthy talks to HealthCor’s Ben Snedeker and Omega Funds founder Otello Stampacchia to find out.Por RBC Capital Markets

D

Driving Digital in Biopharma

1
Digital health and unlocking the value of data 39:59

1+ y ago39:59

39:59

Savyon Amit talks with Tom Lehmann about AstraZeneca's aligned understanding of Digital Health and the importance of articulating the value of digital from an organizational standpoint as well as value to the broader healthcare ecosystem.Por Accenture

D

Driving Digital in Biopharma

1
How a human health care philosophy is shaping a digital transformation 39:52

1+ y ago39:52

39:52

Tom Lehmann talks with Stephen Davies, VP, Eisai Enterprise Information Technology about Eisai’s human health care philosophy. It’s guiding innovation, shaping digital transformation and encouraging a holistic health care view by leveraging technology beyond traditional therapeutics.Por Accenture

P

Pathfinders in Biopharma

1
A call to action: Global Blood Therapeutics on tackling orphan disease 27:33

1+ y ago27:33

27:33

What does it take to tackle the most perplexing orphan diseases? Ted W. Love, M.D., President and CEO, Global Blood Therapeutics (GBT), speaks with RBC Capital Markets’ Senior Biotechnology Analyst Gregory Renza, M.D., about having a mission and the drive to succeed on this episode of Pathfinders.Por RBC Capital Markets

D

Driving Digital in Biopharma

1
Data is the new currency for drug development 42:47

1+ y ago42:47

42:47

In this episode Venkat Sethuraman, SVP Global Biometrics and Data Science, Bristol-Myers Squibb talks with Tom Lehmann about the critical role of data, design and digital in the future vision for R&D.Por Accenture

P

Pathfinders in Biopharma

1
Ionis: Raising The Bar For ESG 23:46

1+ y ago23:46

23:46

In this episode of Pathfinders, Luca Issi, Senior Biotech Analyst at RBC Capital Markets, speaks with Beth Hougen, CFO of Ionis – a leading innovator in the development of antisense medicines and RNA-targeted therapeutics – to find out how the firm is embedding ESG into its vision, strategy and performance.…

D

Driving Digital in Biopharma

1
Decentralized methods and the future of clinical research 46:08

1+ y ago46:08

46:08

Host Tom Lehmann talks with Craig Lipset, a long-time advocate and inspiring innovator in the clinical research and medicine development community. Drawing on his role as co-convenor of the Decentralized Trials and Research Alliance (DTRA), a collaboration of over 120 member organizations, Craig discusses DTRA’s ambitions and priorities for bringin…

P

Pathfinders in Biopharma

1
Biotech and Big Pharma: Blueprint for Successful Partnership 23:11

1+ y ago23:11

23:11

As biotech firms and large pharma companies find new synergies to bring new treatments to market together, Noël Brown, Managing Director and Head of US Biotechnology Investment Banking at RBC Capital Markets, interviews pharma industry veteran, now Biopharma Managing Director, Greg Wiederrecht on what it takes to ensure a strategic partnership not …

D

Driving Digital in Biopharma

1
Life Sciences Tech Trends 2021: From Me to We 17:40

1+ y ago17:40

17:40

Tom Lehmann talks with Frances Taheri, Accenture Ventures Digital Health Lead, about the need for companies to enable their ecosystems to collaborate freely without compromising data security and privacy in the conclusion of our Life Sciences Tech Trends series.Por Accenture

D

Driving Digital in Biopharma

1
Life Sciences Tech Trends 2021: Anywhere, Everywhere 19:42

1+ y ago19:42

19:42

Tom Lehmann talks again with David Hole about the “bring your own environment” (BYOE) model that will drive the industry’s technology agenda in terms of connectivity, collaboration and the tools that enable them in part four of our Life Sciences Tech Trends series.Por Accenture

D

Driving Digital in Biopharma

1
Life Sciences Tech Trends 2021: I, Technologist 16:47

1+ y ago16:47

16:47

Tom Lehmann talks with David Hole, Accenture Life Sciences Talent and Organization Lead, about making technology accessible to all to put powerful capabilities in the hands of people across functions in part three of our Life Sciences Tech Trends series.Por Accenture

D

Driving Digital in Biopharma

1
Life Sciences Tech Trends 2021: Mirrored World 22:06

1+ y ago22:06

22:06

Tom Lehmann talks with Andy Greenberg, Accenture North America Digital Health Lead, about the therapeutic potential of massive, intelligent, digital twins in part two of our Life Sciences Tech Trends series.Por Accenture

D

Driving Digital in Biopharma

1
Life Sciences Tech Trends 2021: Stack Strategically 12:16

1+ y ago12:16

12:16

Host Tom Lehmann begins this special series centered on the 2021 Life Sciences Technology Vision with Shalu Chadha, Accenture Life Sciences Technology Lead, about architecting a better future with technology stacks that are fluid across the ecosystem.Por Accenture

D

Driving Digital in Biopharma

1
In search of the digital thread 39:23

2y ago39:23

39:23

Host Tom Lehmann talks with John Kelleher, head of digital quality for Pfizer global supply. John shares insights on connecting learnings and impacts of a digital QA transformation pilot to a more holistic QC transformation initiative.Por Accenture

B

Biopharma EHS

1
Biopharma EHS Podcast Episode 28 - PDE reports 18:43

2y ago18:43

18:43

BioPharma EH&S Podcast Episode No. 28. Hello everybody and welcome back to another Episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biopharma industry, helping you take your environmental, health and safe…

D

Driving Digital in Biopharma

1
The 4 P's of digital transformation 36:57

2y ago36:57

36:57

Debraj Dasgupta talks with Tom Lehmann about the building blocks and historic obstacles to a successful digital transformation in biopharma.Por Accenture

P

Pathfinders in Biopharma

1
What’s Material in ESG for Biopharma Firms? 18:32

2y ago18:32

18:32

For biopharma companies, ESG commitments can look considerably different from other sectors. We spoke with the team of ESG leads at Gilead Sciences to understand the five key components driving its ESG strategy, how it’s evolved and how it impacts their business.Por RBC Capital Markets

P

Pathfinders in Biopharma

1
Inside Track: Behind the Scenes of a Major Biotech SPAC 23:48

2y ago23:48

23:48

RBC Capital Markets’ Noël Brown, Head of US Biotech Investment Banking, goes behind the scenes of one of the biggest biotech SPAC deals of the year with NuvationBio Founder and CEO, Dr. David Hung and Omega Funds Partner and President of its Omega Alpha SPAC, Michelle Doig. These two industry leaders at the cutting edge of biotech innovation and ve…

D

Driving Digital in Biopharma

1
Digital’s positive role in patient health 33:55

2y ago33:55

33:55

Tom Lehmann discusses tapping into digital to achieve greater patient-centricity with Jen Spada and Tina Ripperger.Por Accenture

P

Pathfinders in Biopharma

1
Biotech SPACs: A new route to going public 30:22

2y ago30:22

30:22

As more firms and investors look to SPACs as an IPO alternative, will this change the way biotech companies access public markets long-term? Our investment banking team goes inside the SPAC boom to explain what companies need to know before choosing their path to going public.Por RBC Capital Markets

D

Driving Digital in Biopharma

1
Digital is greater than technology 29:40

2+ y ago29:40

29:40

Tom Lehmann discusses digital strategy and transformation wins with Guido Radack, Vice President, Strategic Initiatives Leader at Bayer.Por Accenture

D

Driving Digital in Biopharma

1
Digital at the Pace of Science 38:03

2+ y ago38:03

38:03

Host Tom Lehmann talks with Kailash Swarna, global head of R&D digitalization strategy at NovoNordisk about data complexity, measuring digital value, keeping pace with the next generation of science and patient centricity.Por Accenture

P

Pathfinders in Biopharma

1
Vida Ventures: Powering Breakthroughs in Biopharma 22:57

2+ y ago22:57

22:57

Luca Issi, Senior Biotechnology Research Analyst at RBC Capital Markets, discusses the art of building biopharma breakthroughs with Arjun Goyal, Co-Founder and Managing Director of Vida Ventures. Key Points Maturation of the industry is increasing innovation and capital inflows Strong science, management and investors can keep the IPO window open…

P

Pathfinders in Biopharma

1
5AM Ventures: Fueling the Next Generation of Innovators 19:14

2+ y ago19:14

19:14

In this episode of Pathfinders, Brian Abrahams, Managing Director and Co-Head of Biotechnology Equity Research at RBC Capital Markets speaks with Andy Schwab, Co-Founder and Managing Partner at 5AM Ventures. Key Points Prescription Digital Therapeutics will be vital to future treatment Unlocking microbiome could lead to better disease management…

P

Pathfinders in Biopharma

1
Biotech IPOs: Navigating the New Landscape 20:00

2+ y ago20:00

20:00

Even in a boom, many biotech executives may be unprepared for the risks involved in undertaking an IPO. Noël Brown and Tim Papp, Managing Directors focused on biotechnology in our Global Healthcare Investment Banking and Jason Levitz, Head of Healthcare Equity Capital Markets at RBC Capital Markets discuss the right steps to take, and the pitfalls …

Podcasts que valem a pena ouvir

PATROCINADO

Podcasts sobre Biopharma

Download the App!

Podcasts que valem a pena ouvir

PATROCINADO

Guia rápido de referências